Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review Article

Full Text via DOI: 10.1080/14737167.2019.1592834 PMID: 30870051 Web of Science: 000465111900001
International Collaboration

Cited authors

  • Deitelzweig, Steve; Lip, Gregory Y. H.

Publication date

  • 2019

International Standard Serial Number (ISSN)

  • 1473-7167

Start page

  • 243

End page

  • 244

Volume

  • 19

Issue

  • 3